Interim CEO - Mark McDonough
Mark McDonough serves as Interim CEO of Cyrex Labs as of May 2024. Prior to this, he served in several private and public company CEO roles to include PierianDx and CombiMatrix, a publicly held molecular diagnostics company performing DNA-based testing services for reproductive health, oncology, and developmental disorders.
As CEO of CombiMatrix, from 2013-2017, Mark led a dramatic turnaround of a struggling company with a precise focus on high margin growth coupled with disciplined cost reduction. CombiMatrix revenue grew 300% over his tenure and achieved profitability. At PierianDx, he led 40% revenue growth in back-to back years leading to significant Private Equity interest. Mark has also held executive and management positions with US LABS (acquired by LabCorp) and Ventana Medical Systems (acquired by Roche). Mark is the Founder and CEO of McDonough Leadership Advisors, a private consulting firm specializing in company, culture, and commercial growth expertise.